Yale-New Haven Hospital- Yale Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06510.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Yale-New Haven Hospital- Yale Cancer Center has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Yale-New Haven Hospital- Yale Cancer Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale-New Haven Hospital- Yale Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer.
Yale-New Haven Hospital- Yale Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.